Variant report
Variant | nsv977370 |
---|---|
Chromosome Location | chr13:63494324-63516765 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:1)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
(count:1 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-PCDH20-20 | chr13:63506481-63506671 | NONHSAT034156 |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs568844704 | chr13:63494414-63494415 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs184800345 | chr13:63494464-63494465 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs572112718 | chr13:63494466-63494467 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs77834418 | chr13:63494482-63494483 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs374416048 | chr13:63494497-63494498 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs565188640 | chr13:63494502-63494503 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs78404993 | chr13:63494560-63494561 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs371501701 | chr13:63494561-63494562 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs188444327 | chr13:63494563-63494564 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs532768317 | chr13:63494571-63494572 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs550889531 | chr13:63494579-63494580 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs530345599 | chr13:63494603-63494604 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs78864056 | chr13:63494623-63494624 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs139244701 | chr13:63494676-63494677 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs527832980 | chr13:63494687-63494688 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs552295337 | chr13:63494689-63494690 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs536560765 | chr13:63494774-63494775 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs570552720 | chr13:63494839-63494840 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs80031526 | chr13:63494844-63494845 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs73200884 | chr13:63494862-63494863 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
21 | rs568034471 | chr13:63494963-63494964 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs535758675 | chr13:63494986-63494987 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs139805889 | chr13:63495029-63495030 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs145300772 | chr13:63495046-63495047 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs539709852 | chr13:63495063-63495064 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs539255718 | chr13:63495070-63495071 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs111998287 | chr13:63495216-63495217 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs576913480 | chr13:63495321-63495322 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs544231095 | chr13:63495348-63495349 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs148670889 | chr13:63495379-63495380 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs200365892 | chr13:63495420-63495421 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs34991726 | chr13:63495421-63495422 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs369916773 | chr13:63495424-63495425 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs55819247 | chr13:63495425-63495426 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs574449632 | chr13:63495458-63495459 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs542510769 | chr13:63495531-63495532 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs2139849 | chr13:63495540-63495541 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
38 | rs74406181 | chr13:63495552-63495553 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs80224956 | chr13:63495599-63495600 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs370550517 | chr13:63495643-63495644 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs564196751 | chr13:63495778-63495779 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs149041971 | chr13:63495781-63495782 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs578012138 | chr13:63495843-63495844 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs73200886 | chr13:63495853-63495854 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs566995879 | chr13:63495854-63495855 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs398023078 | chr13:63495857-63495858 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs560394886 | chr13:63495877-63495878 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs142097118 | chr13:63495933-63495934 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs184729921 | chr13:63495991-63495992 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs528837556 | chr13:63496136-63496137 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Prostate cancer | 16705090 | CNVD |
High-proliferative meningiomas | 17937814 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cancer | 20164919 | CNVD |
Autism | 22495311 | CNVD |
Chordoma | 21602918 | CNVD |
Bladder cancer | 21949216 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Cancer | 21637783 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Chronic lymphocytic leukemia | 21518781 | CNVD |
colon cancer | 17210682 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Intracranial aneurysm | 19064780 | CNVD |
Breast cancer | 19287154 | CNVD |
Acute myeloid leukemia | 18379011 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Olfactory neuroblastoma | 18408657 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Ependymoma | 16718352 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Colorectal cancer | 16272173 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Breast cancer | 16608533 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Breast cancer | 17133270 | CNVD |
Myoepithelioma | 18604193 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
Prostate cancer | 16573809 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Paraganglioma | 21461997 | CNVD |
Pheochromocytoma | 21461997 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Prostate cancer | 17245344 | CNVD |
Prostate cancer | 18632612 | CNVD |
Colorectal cancer | 21586687 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Retinoblastoma | 19183342 | CNVD |
Developmental delay | 21147756 | CNVD |
Melanoma | 18172304 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Merkel cell carcinoma | 19020549 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Non-syndromic sensorineural hearing loss | 18496225 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Breast cancer | 21858162 | CNVD |
Glioblastoma multiforme | 21922591 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Gastric cancer | 17908304 | CNVD |
Glioblastoma multiforme | 21750150 | CNVD |
Breast cancer | 17603634 | CNVD |
Cancer | 21183584 | CNVD |
Breast cancer | 17393978 | CNVD |
Splenic marginal zone lymphoma | 18492102 | CNVD |
Liposarcoma | 21253554 | CNVD |
Gastrointestinal stromal cancer | 20818650 | CNVD |
head and neck squamous cell carcinoma | 17671120 | CNVD |
Colorectal cancer | 16774939 | CNVD |
Adenoid cystic carcinoma | 17372589 | CNVD |
abnormal development | 18461090 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Chronic lymphocytic leukemia | 20421269 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Myelofibrosis | 22110671 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Lung cancer | 18438408 | CNVD |
Bipolar disorder | 19114987 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr13:63493800-63494800 | Enhancers | Foreskin Fibroblast Primary Cells skin01 | Skin |
2 | chr13:63493800-63495600 | Enhancers | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
3 | chr13:63494000-63502600 | Weak transcription | H1 Derived Mesenchymal Stem Cells | ES cell derived |
4 | chr13:63494600-63495000 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
5 | chr13:63494600-63495600 | Enhancers | NHDF-Ad | bronchial |
6 | chr13:63502200-63502600 | Active TSS | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
7 | chr13:63502600-63502800 | Enhancers | H1 Derived Mesenchymal Stem Cells | ES cell derived |
8 | chr13:63503600-63504000 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
9 | chr13:63505200-63505600 | Enhancers | Foreskin Fibroblast Primary Cells skin01 | Skin |
10 | chr13:63505400-63505600 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
11 | chr13:63505400-63505800 | Enhancers | NHDF-Ad | bronchial |
12 | chr13:63505400-63508200 | Enhancers | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
13 | chr13:63505600-63506200 | Flanking Active TSS | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
14 | chr13:63505600-63506200 | Enhancers | Rectal Smooth Muscle | rectum |
15 | chr13:63505600-63507000 | Enhancers | Dnd41 | blood |
16 | chr13:63505800-63506000 | Flanking Active TSS | NHDF-Ad | bronchial |
17 | chr13:63505800-63506200 | Enhancers | Foreskin Fibroblast Primary Cells skin01 | Skin |
18 | chr13:63506000-63506400 | Enhancers | Colon Smooth Muscle | Colon |
19 | chr13:63506000-63506400 | Active TSS | NHDF-Ad | bronchial |
20 | chr13:63506200-63507000 | Active TSS | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
21 | chr13:63507000-63507600 | Weak transcription | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
22 | chr13:63507000-63508000 | Weak transcription | Dnd41 | blood |
23 | chr13:63507600-63508400 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
24 | chr13:63508000-63508200 | Enhancers | Dnd41 | blood |